Embecta Corporation’s Strategic Shifts and Revenue Outlook Prompt ‘Sell’ Rating
Embecta Corporation (EMBC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Travis ...
Embecta upgraded to Buy from Neutral at BTIG
BTIG upgraded Embecta (EMBC) to Buy from Neutral with a $26 price target Shares gained about 30% in Tuesday trading as investors rewarded ...
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, ...
Embecta raised to buy at BTIG after Q4 update
Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 results. Read more here.
Embecta Corp. (NASDAQ:EMBC) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript November 26, 2024 Embecta Corp. misses on earnings expectations. Reported EPS is $ EPS, ...
Embecta to discontinue insulin patch pump program, initiates restructuring plan
Kurdikar, CEO of Embecta (EMBC) said, “As our stand-up work nears completion and following an in-depth review of our ...
Embecta Corp (EMBC) Q4 2024 Earnings Call Highlights: Strategic Shifts and Financial Performance
Embecta Corp (EMBC) reports a 4.1% revenue increase while navigating restructuring and future growth opportunities.
Q4 2024 Embecta Corp Earnings Call
Good day, and welcome to the Embecta fourth quarter of fiscal year 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like ...
These Stocks Moved the Most Today: GM, Amgen, Lilly, Super Micro, Best Buy, Rivian, NRG Energy, Kohl’s, and More
Shares of General Motors and Ford fall after President-elect Donald Trump announces his tariff plans, while Amgen tumbles as ...